We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $5.69B
1-Year Est. Return 60.64%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+60.64%
3 Year Est. Return
+143.93%
5 Year Est. Return
+204.18%
10 Year Est. Return
+832.04%
AUM
$5.69B
AUM Growth
+$717M
Cap. Flow
+$39.1M
Cap. Flow %
0.69%
Top 10 Hldgs %
7.69%
Holding
1,326
New
105
Increased
437
Reduced
332
Closed
93

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$27.3M
2
DHT icon
DHT Holdings
DHT
+$21.2M
3
VVX icon
V2X
VVX
+$19M
4
SDRL icon
Seadrill
SDRL
+$13.2M
5
VSAT icon
Viasat
VSAT
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 28.79%
2 Consumer Discretionary 13.92%
3 Technology 13.18%
4 Industrials 10.69%
5 Energy 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APAM icon
801
Artisan Partners
APAM
$2.92B
$656K 0.01%
19,000
-10,000
-34% -$368K
SWIM icon
802
Latham Group
SWIM
$794M
$653K 0.01%
100,972
CNDT icon
803
Conduent
CNDT
$257M
$653K 0.01%
447,382
-375,000
-46% -$582K
SGA icon
804
Saga Communications
SGA
$56.3M
$653K 0.01%
71,961
+400
+0.6% +$4.1K
TROX icon
805
Tronox
TROX
$767M
$646K 0.01%
102,558
-793,819
-89% -$6.73M
HNVR icon
806
Hanover Bancorp
HNVR
$191M
$644K 0.01%
27,624
IMMR icon
807
Immersion
IMMR
$253M
$642K 0.01%
94,800
+50,000
+112% +$315K
PLRX icon
808
Pliant Therapeutics
PLRX
$70.3M
$631K 0.01%
553,630
DDD icon
809
3D Systems Corp
DDD
$562M
$624K 0.01%
206,500
+45,000
+28% +$123K
CCCC icon
810
C4 Therapeutics
CCCC
$437M
$612K 0.01%
131,100
NNBR icon
811
NN Inc
NNBR
$309M
$610K 0.01%
169,962
AVIR icon
812
Atea Pharmaceuticals
AVIR
$456M
$609K 0.01%
130,900
-17,500
-12% -$87K
OSUR icon
813
OraSure Technologies
OSUR
$234M
$603K 0.01%
135,159
-149,404
-53% -$528K
RCMT icon
814
RCM Technologies
RCMT
$289M
$602K 0.01%
21,342
III icon
815
Information Services Group
III
$246M
$592K 0.01%
143,961
+2,100
+1% +$8.78K
NGNE icon
816
Neurogene
NGNE
$763M
$591K 0.01%
18,781
BDSX icon
817
Biodesix
BDSX
$281M
$587K 0.01%
26,035
+15,000
+136% +$222K
CVGI icon
818
Commercial Vehicle Group
CVGI
$129M
$584K 0.01%
126,446
+28,643
+29% +$134K
CCRN
819
DELISTED
Cross Country Healthcare
CCRN
$582K 0.01%
44,081
-61,207
-58% -$725K
BGSF icon
820
BGSF Inc
BGSF
$57M
$580K 0.01%
101,635
+2,879
+3% +$16K
PMVP icon
821
PMV Pharmaceuticals
PMVP
$71.6M
$575K 0.01%
428,853
CIX icon
822
Comp X International
CIX
$458M
$564K 0.01%
22,667
-1,000
-4% -$24.2K
ALCO icon
823
Alico
ALCO
$295M
$564K 0.01%
13,638
+200
+1% +$8.29K
ISBA
824
Isabella Bank
ISBA
$302M
$562K 0.01%
14,240
SPIR icon
825
Spire Global
SPIR
$493M
$558K 0.01%
30,000
-22,500
-43% -$418K

Similar funds

Bridgeway Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Bridgeway Capital Management held 1,326 positions worth $5.69B, up 14% from $4.97B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Bridgeway Capital Management's Q2 2026 filing shows 105 new, 437 increased, 332 reduced and 93 closed positions. Its largest new stake was PagSeguro Digital: 1,364,381 shares worth $12.3M. The largest sale was Advanced Micro Devices, an estimated $27.3M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridgeway Capital Management's largest Q2 2026 buy was PagSeguro Digital: 1,364,381 shares worth $12.3M.
  • Bridgeway Capital Management added most to Vistance Networks Inc in Q2 2026, an estimated $17.7M increase.
  • Bridgeway Capital Management's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $27.3M.
  • Bridgeway Capital Management fully exited DHT Holdings in Q2 2026, selling an estimated $21.2M.
  • Bridgeway Capital Management's ten largest holdings make up 7.7% of its $5.69B portfolio in Q2 2026.
  • Bridgeway Capital Management opened 105 new positions and closed 93 in Q2 2026.
  • Bridgeway Capital Management's portfolio value rose 14% quarter-over-quarter to $5.69B.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.